TY - JOUR A1 - Voss, L. A1 - Saloga, Patrick E. J. A1 - Stock, V. A1 - Böhmert, L. A1 - Braeuning, A. A1 - Thünemann, Andreas A1 - Lampen, A. A1 - Sieg, H. T1 - Environmental impact of ZnO nanoparticles evaluated by in vitro simulated digestion N2 - ZnO nanoparticles are found in different food and consumer products, and their toxicological effects are still under investigation. It is therefore important to understand their behavior in the gastrointestinal tract. Here, we used an in vitro model to assess the physicochemical fate of ZnO nanoparticles during the digestive process in artificial saliva, stomach juice, and intestinal juice. Atomic absorption spectrometry and small-angle X-ray scattering were employed to investigate two ZnO nanomaterials, one intensively characterized reference material and soluble ZnCl2 in a broad range of concentrations between 25 and 1000 μg/mL in the intestinal fluid. Because food components may influence the behavior of nanomaterials in the gastrointestinal tract, starch, milk powder, and olive oil were used to mimic carbohydrates, protein, and fat, respectively. Additionally, ion release of all Zn species was assessed in cell culture media and compared to artificial intestinal juice to investigate relevance of typical cell culture conditions in ZnO nanotoxicology. ZnCl2 as well as the ZnO species were present as particles in artificial saliva but were solubilized completely in the acidic stomach juice. Interestingly, in the intestinal fluid a concentration-independent de novo formation of particles in the nanoscale range was shown. This was the case for all particles as well as for ZnCl2, regardless of the concentration used. Neither of the food components affected the behavior of any Zn species. On the contrary, all Zn species showed a Zn-concentration-dependent ion release in common cell culture medium. This questions the suitability of cell culture studies to investigate the effect of ZnO nanoparticles on intestinal cells. Our results show that Zn-containing nanoparticles reach the intestine. This underlines the importance of determining the influence of the test environment on nanoparticle fate. KW - SAXS KW - Digestion KW - Zinc oxide KW - Nanoparticles PY - 2020 DO - https://doi.org/10.1021/acsanm.9b02236 VL - 3 IS - 1 SP - 724 EP - 733 AN - OPUS4-50288 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Sieg, H. A1 - Lehmann, C. A1 - Kästner, Claudia A1 - Krause, B. A1 - Burel, A. A1 - Chevance, S. A1 - Böhmert, L. A1 - Lichtenstein, D. A1 - Tentschert, J. A1 - Bräuning, A. A1 - Laux, A. A1 - Thünemann, Andreas A1 - Loipis, I. E. A1 - Fessard, V. A1 - Luch, A. A1 - Lampen, A. T1 - Effects of Al-, Ti- and Zn-containing nanomaterials on cell lines in vitro N2 - Among the different tested endpoints, Al- and Ticontaining nanomaterials did notshowany toxicity in intestinal cell lines in vitro. Nevertheless, this absence of effect was not due to an absence of exposure, since particle-specific uptake was reported. Metal particle uptake over a long time period might therefore be relevant for risk assessment of aluminum- and titanium-containing food products. T2 - 52nd Congress of the European-Societies-of-Toxicology (EUROTOX) CY - Seville, Spain DA - 04.09.2017 KW - Nanoparticles PY - 2017 DO - https://doi.org/10.1016/j.toxlet.2016.06.1954 SN - 0378-4274 VL - 258 SP - S272 PB - Elsevier Ltd. AN - OPUS4-40939 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Voss, L. A1 - Hoche, E. A1 - Stock, V. A1 - Böhmert, L. A1 - Braeuning, A. A1 - Thünemann, Andreas A1 - Sieg, H. T1 - Intestinal and hepatic effects of iron oxide nanoparticles N2 - Iron oxide nanoparticles gain increasing attention due to their broad industrial use. However, safety concerns exist since their effects on human cells are still under investigation. The presence of iron oxide nanoparticles in the food pigment E172 has been shown recently. Here, we studied four iron oxide nanoparticles, one food pigment E172 and the ionic control FeSO4 regarding dissolution in biological media, uptake and transport, and cellular effects in vitro in human intestinal Caco-2 and HepaRG hepatocarcinoma cells. The iron oxide nanoparticles passed the gastrointestinal passage without dissolution and reached the intestine in the form of particles. Minor uptake was seen into Caco-2 cells but almost no transport to the basolateral site was detected for any of the tested particles. HepaRG cells showed higher particle uptake. Caco-2 cells showed no alterations in reactive oxygen species production, apoptosis, or mitochondrial membrane potential, whereas two particles induced apoptosis in HepaRG cells, and one altered mitochondrial membrane potential at non-cytotoxic concentrations. No correlation between physicochemical particle characteristics and cellular effects was observed, thus emphasizing the Need for case-by-case assessment of iron oxide nanoparticles. KW - Nanoparticles PY - 2021 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-521651 DO - https://doi.org/10.1007/s00204-020-02960-7 VL - 95 IS - 3 SP - 895 EP - 905 PB - Springer AN - OPUS4-52165 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Sieg, H. T1 - Artificial digestion of aluminium-containing nanomaterials and their effects on the gastrointestinal tract in vitro N2 - Although aluminium is one of the most common elements in the biosphere, up to now little is known about its impact on human health. aluminium and its chemical derivatives are highly abundant in food, food contact materials and consumer products. Humans are exposed to aluminium via the gastrointestinal tract (GI tract). Exposition can change substantially due to consumer behavior since aluminium is also a compound of numerous food additives. Recently, aluminium exposition is increasingly considered to cohere with cancer and neurodegenerative disorders. Lately, due to an increasing attentiveness on this topic, limiting values for food additives have been tightened by the EFSA. However, cellular effects of aluminium and especially aluminium-containing nanomaterials, that represent a significant part of chemicals found in food products, are widely unknown and in the focus of our research activities, for example in the bilateral SolNanoTOX project. We established an in vitro simulation system of the GI tract, where nanomaterials undergo the different physiological, chemical and proteinbiochemical conditions of saliva, gastric juice and the intestine. The artificially digested nanomaterials, as well as soluble aluminium chloride as ionic control substance, were subjected to several analytical and biochemical methods to characterize their change of appearance and their cytotoxic effects on intestinal cellular models. We observed the fate of the nanomaterials during typical pH-values of saliva, gastric and intestinal juice with Dynamic light scattering measurements and ICP-MS in the single particle mode. After observable disappearance at pH 2 the particles recovered in the simulated intestinal fluid. The simulation of the GI tract, mainly the change of pH settings, can lead to a certain chemical activation of aluminium that can increase bioavailability in the intestine after oral uptake of aluminium-containing food products. In vitro assays like CTB, MTT and cellular impedance measurements showed that there were no acute cytotoxic effects measurable after a period up to 48h after incubation, comparable to undigested particles. In contrast, high amounts of aluminium ions showed synergistic effects on cell viability compared to non-digested aluminium ions. Although toxicological potential of Al ions to healthy tissue appears to be low, increased hazardous potential cannot be ruled out to pre-damaged tissue and can have a relevance in risk assessment for special consumer groups with for example chronical intestinal inflammation or dietary eating behavior combined with high exposure to Al-containing food products. T2 - 82nd Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology CY - Berlin, Germany DA - 29.02.2016 KW - Nanoparticles KW - Digestion KW - SAXS KW - Cytotoxicity PY - 2016 AN - OPUS4-36026 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -